ClinicalTrials.gg
CompletedNCT03312790Updated Oct 18, 2017

Effects of Augmented Reality on Humans

An interventional study of Tasks in Physical Activity and Mental Status Change, sponsored by University of Burgundy. Completed at 1 site in France. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-18.

Primary conditionFatigueRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Fatigue
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's title name Fatigue.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Burgundy · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Feb 2017, registered Jun 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 104 studies in Fatigue with a site in France — 33 open to participants now, 36 under way, 3 of them phase 3. Fatigue · France.

Enrollment
68th of 72
12 · median 70
Started
2017
with 5 others
No phase
61 of 104
23 open now
Registered
27th of 104
by date

Among the 104 studies in Fatigue with a site in France, this one is the 68th largest by enrollment of the 72 interventional ones that give a count, is one of 6 that started in 2017, is one of 61 with no phase, and was the 27th registered.

Fatigue

2,229 studies on the registry are indexed under Fatigue; 426 are open to participants now.

Browse Fatigue studies →

Open to participants now

33 of the 104 studies in Fatigue with a site in France are open now. Recruiting first, the newest first:

28 more — sign in →

All 33 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 240 Fatigue studies recruiting now, 112 (47%) set no upper age limit and 98 (41%) stop at 75 or younger; 24 take children under 18; 74 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 104 studies in Fatigue with a site in France, or all of them as a file.
02

Study summary

Nowadays, augmented reality (AR) has gained attention but little is known concerning its repercussion in individuals when considering some mental and physiological aspects. Therefore, the aim of this study was to investigate the effects of AR glasses on some cognitive and physiological functions in an attempt to determine its safety for workers.

Read the detailed description

Twelve volunteers were tested during two separate randomized sessions: one with AR glasses (ARGlass) and one in normal condition (Normal). Participants had two perform different tasks of a 90 minutes total duration. Before, during and after these tasks, two feet balance, one foot balance, precision balance, stroop and memory tests were performed. Also, heart rate and electromyographic activity of some muscles were recorded. Finally a survey was filled to determine, for example fatigue, pain or comfort.

03

Conditions studied

  • Physical Activity
  • Mental Status Change

Browse trials for

Keywords

  • augmented reality
  • fatigue
  • muscle
  • heart rate
  • mental function
04

In context

Fatigue Reclassified

2,229 studies on the registry are indexed under Fatigue; 426 are open to participants now.

This study's enrollment of 12 is below the median of 54 across 1,757 interventional studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

University of Burgundy is the lead sponsor of 12 studies on the registry; 2 are open to participants now.

Compared within Fatigue, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy
  • \< 27
  • physically active
  • written form

Exclusion criteria

Exclusion Criteria:

  • in-habitual fatigue
  • taking drugs and alcohol more than twice a day
  • potential psychomotor disease
  • injury in the preceding 3 months
  • no healthcare
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    augmented reality device

    Tasks realized using augmented reality device

    Device: Tasks

  • Other
    Real condition

    Same tasks than augmented reality realized in normal/real condition

    Device: Tasks

Interventions

  • DeviceTasks

    Augmented reality device Real condition

    Also known as: Workers tasks

07

What researchers measure

Primary outcomes

  1. Voluntary activation using electromyography of upper and lower limb muscles

    The mean electromyographic activity of trapezius, deltoideus, biceps brachii, latissimus dorsi, soleus and tibialis anterior muscles will be measured using surface electrodes

    Time frame: Measured just before and immediately after every 30 minutes series (repeated three times)

Secondary outcomes

  1. Heart rate

    Heart rate during the different tasks and test session

    Time frame: Measured just before and immediately after every 30 minutes series (repeated three times)

  2. Balance

    Two feet, one foot and precision tasks balance (center of pressure displacement)

    Time frame: Measured just before and immediately after every 30 minutes series (repeated three times)

  3. Memory

    5 words memory test

    Time frame: Measured just before and immediately after every 30 minutes series (repeated three times)

  4. attention

    Stroop test

    Time frame: Measured just before and immediately after every 30 minutes series (repeated three times)

  5. subjective perceived exertion

    difficulty of the tasks using a visual analogic scale

    Time frame: Measured just before and immediately after every 30 minutes series (repeated three times)

  6. subjective pain perception

    pain perceived (visual analogic scale) and the location if some pain sensation

    Time frame: Measured just before and immediately after every 30 minutes series (repeated three times)

  7. subjective fatigue perception

    perceived fatigue (visual analogic scale) and the location in case of fatigue feeling

    Time frame: Measured just before and immediately after every 30 minutes series (repeated three times)

08

Study locations

1 site
  • Centre d'Expertise de la Performance - Université de Bourgogne
    Dijon, 27877, France
09

References and documents

Publications

  • Babault N, Paizis C, Deley G, Guerin-Deremaux L, Saniez MH, Lefranc-Millot C, Allaert FA. Pea proteins oral supplementation promotes muscle thickness gains during resistance training: a double-blind, randomized, Placebo-controlled clinical trial vs. Whey protein. J Int Soc Sports Nutr. 2015 Jan 21;12(1):3. doi: 10.1186/s12970-014-0064-5. eCollection 2015. PubMed 25628520 ↗

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2017 to primary completion in Feb 2017, 0 months.

Of 936 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's 0 months is below that.

Counting every sponsor, half of 989 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2017
First posted
Oct 18, 2017
StartActual
Feb 1, 2017
Primary completionActual
Feb 15, 2017
CompletionActual
Mar 1, 2017
Last update
Oct 18, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03312790
Lead sponsor
University of Burgundy
Responsible party
Nicolas Babault (principal investigator, University of Burgundy) — Principal investigator
First posted
Oct 18, 2017
Start date
Feb 1, 2017
Primary completion
Feb 15, 2017
Completion
Mar 1, 2017
Last update
Oct 18, 2017

Study contacts

Nicolas Babault, PhD
principal investigator · University of Burgundy

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion